ArticleDermatology and therapy2023

Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study.

Pablo Fernandez-Crehuet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.